Hepatic perfusion abnormalities during treatment with hepatic arterial infusion chemotherapy: Value of CT arteriography using an implantable port system

Journal of Computer Assisted Tomography

Volumn 20, Issue 3, 1996, Pages 343-348

  Seki, Hiroshi ^a   Kimura, Motomasa ^a   Kamura, Takeshi ^a   Miura, Tsutomu ^a   Yoshimura, Norihiko ^a   Sakai, Kunio ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Arteries, hepatic; Chemotherapy; Computed tomography; Liver, neoplasms

Indexed keywords

ANGIOGRAPHY; COMPUTERIZED TOMOGRAPHY; TUMORS;

ARTERIAL INFUSION CHEMOTHERAPIES; ARTERY, HEPATIC; COMPUTED TOMOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; HYPOPERFUSION; INFUSION PUMP; LIVER NEOPLASMS; LIVER TUMORS; PERFUSION ABNORMALITIES; PROGRESSIVE DISEASE;

CHEMOTHERAPY;

CISPLATIN; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; IOPAMIDOL; MITOMYCIN C;

ARTICLE; BILE DUCT CARCINOMA; CANCER COMBINATION CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER ARTERIOGRAPHY; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER PERFUSION; MALE; PRIORITY JOURNAL; REGIONAL PERFUSION; VASCULAR ACCESS;

EID: 0029940824     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004728-199605000-00002     Document Type: Article

References (22)

1. Arai Y, Endo T, Sone Y, et al. Management of patients with unresectable liver metastases from colorectal and gastric cancer employing an implantable port system. Cancer Chemother Pharmacol 1992;31:S99-102.
2. Buchwald H, Grage TB, Vassilopoulus PP, Ronde TD, Varco RL, Blackshear PJ. Intraarterial infusion chemotherapy for hepatic carcinoma using a totally implantable infusion pump. Cancer 1980;45:866-9.
3. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987;206:685-93.
4. Miller DL, Carrasquillo JA, Lutz RJ, Chang AE. Hepatic perfusion during hepatic artery infusion chemotherapy: evaluation with perfusion CT and perfusion scintigraphy. J Comput Assist Tomogr 1989;13:958-64.
5. Roth J, Wallner B, Safi F. Arterial perfusion abnormalities of the liver after hepatic arterial infusion chemotherapy and their correlation with changes in the metastases: evaluation with CT and angiography. AJK 1989;153:751-4.
6. Freeny PC, Marks WM. Hepatic perfusion abnormalities during CT angiography: detection and interpretation. Radiology 1986;159:685-91.
7. Seki H, Higuchi S, Hatakeyama S, Takagi K, Hasegawa M, Manabe K. Usefulness of computed tomographic arteriography of the liver through an implantable injection port. Jpn J Clin Radiol 1993;38:545-50.
8. Kaplan WD, Ensminger WD, Come SE, et al. Radionuclide angiography to predict patient response to hepatic arterial chemotherapy. Cancer Treat Rep 1980;64:1217-22.
9. Sanchez FW, Chuang VP, Murray DR, Bried J, Skolkin MD. DSA evaluation of surgically implanted infusaid pump-catheter systems. AJR 1986;146:839-41.
10. Lehner K, Reiser M, Gebhardt U, Heuck A, Schaff J. DSA-control of implanted devices for arterial hepatic perfusion. Cardiovasc Intervent Radiol 1987;10:71-1.
11. Andrews JC, Williams DM, Cho KJ, Knol JA, Wahl RL, Ensminger WD. Unsatisfactory hepatic perfusion after placement of an implanted pump and catheter system: angiographic correlation. Radiology 1989;173:779-81.
12. Civelek AC, Sitzmann JV, Clin BB, Venbrux A, Wanger HN Jr, Grochow LB. Misperfusion of the liver during hepatic artery infusion chemotherapy: value of preoperative angiography and postoperative pump scintigraphy. AJR 1993;160: 865-70.
13. 99mTc-MAA hepatic arterial perfusion scintigraphy. AJR 1985;145:747-51.
14. Bledin AG, Kim EE, Chuang VP, Wallace S, Haynie TP. Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intraarterially injected technetium 99m macroaggregated albumin. Br J Radiol 1984;57: 197-203.
15. Pozniak MA, Babel SG, Trump DL. Complications of hepatic arterial infusion chemotherapy. Radiographics 1991; 11:67-79.
16. Hohn DC, Rayner AA, Economou JS, Ignoffo RJ, Lewis BJ, Stagg RJ. Toxicities and complications of implanted pump hepatic arterial and intravenous floxuridine infusion. Cancer 1986;57:465-70.
17. Charnsangavej C, Chuang VP, Wallace S, Soo CS, Bowers T. Angiographic classification of hepatic arterial collaterals. Radiology 1982;144:485-94.
18. Charnsangavej C, Kirk IR, Dubrow RA, et al. Arterial com plications from long-term hepatic artery chemoinfusioti catheters: evaluation with CT. AJR 1993;160:859-64.
19. Andrews JC, Griggs TJ, Ensminger WD, Gyves JW, Cho KJ. Local thrombolytic therapy for hepatic artery thrombosis following chemotherapy infusion catheter placement. Invest Radiol 1987;22:467-71.
20. Aoki T, Inoue K, Tsuchida A, et al. A study of various complications in arterial infusion chemotherapy. Jpn J Cancer Chemother 1994;21:2649-54.
21. Forsberg L, Hafstrom L, Lunderquist A, Sundqvist K. Arterial changes during treatment with intrahepatic arterial infusion of 5-fluorouracil. Radiology 1978;126:49-52.
22. Ueda E, Sako M, Hirota S. Experimental and clinical study of arterial damage induced by anti-cancer drug infusion. Nippon Acta Radiol 1992;52:960-70.